APO Research
Talk to an analyst

APO RESEARCH · REPORT

Poliovirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Poliovirus Vaccine Industry Growth and Trends Forecast to 2032

22 December 202590 pages

Choose your research edition.

Industry ResearchPoliovirus Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Poliovirus Vaccine Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Poliovirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Poliovirus Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Poliovirus Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Poliovirus Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Poliovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Poliovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Poliovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Poliovirus Vaccine include Sanofi, GSK, Tiantan Biological, Serum Institute, Panacea Biotec Ltd, IMBCA, Halfkin Bio-Pharmaceuticals, Bio-Med and Bibcol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Poliovirus Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Poliovirus Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Poliovirus Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Poliovirus Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Poliovirus Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Poliovirus Vaccine Market by Company

Sanofi

GSK

Tiantan Biological

Serum Institute

Panacea Biotec Ltd

IMBCA

Halfkin Bio-Pharmaceuticals

Bio-Med

Bibcol

Poliovirus Vaccine Segment by Type

Inactivated Polio Vaccine (IPV)

Oral Polio Vaccine (OPV)

Poliovirus Vaccine Segment by Application

Public

Private

Poliovirus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poliovirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poliovirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poliovirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Poliovirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Poliovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inactivated Polio Vaccine (IPV) Table 2. Major Company of Oral Polio Vaccine (OPV) Table 3. Global Poliovirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Poliovirus Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Poliovirus Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Poliovirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Poliovirus Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Poliovirus Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global Poliovirus Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Poliovirus Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Poliovirus Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Poliovirus Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Poliovirus Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America Poliovirus Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Poliovirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Poliovirus Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Poliovirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Poliovirus Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Poliovirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Poliovirus Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Poliovirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Poliovirus Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Poliovirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Poliovirus Vaccine Industry Trends Table 25. Poliovirus Vaccine Industry Drivers Table 26. Poliovirus Vaccine Industry Opportunities and Challenges Table 27. Poliovirus Vaccine Industry Restraints Table 28. Global Poliovirus Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Poliovirus Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Poliovirus Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Poliovirus Vaccine Sales Share by Company (2021-2026) Table 32. Global Poliovirus Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Poliovirus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Poliovirus Vaccine Major Company Production Sites and Headquarters Table 35. Global Poliovirus Vaccine Company, Product Type & Application Table 36. Global Poliovirus Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Poliovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Poliovirus Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Poliovirus Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Poliovirus Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Poliovirus Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Poliovirus Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Poliovirus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Poliovirus Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Poliovirus Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Poliovirus Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Poliovirus Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Poliovirus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Poliovirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Poliovirus Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Poliovirus Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Poliovirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Poliovirus Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Poliovirus Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Poliovirus Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Poliovirus Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Poliovirus Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Poliovirus Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Poliovirus Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America Poliovirus Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Poliovirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Poliovirus Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Poliovirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Poliovirus Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Poliovirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Poliovirus Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Poliovirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Poliovirus Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Poliovirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Poliovirus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Sanofi Poliovirus Vaccine Product Portfolio Table 75. Sanofi Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Poliovirus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. GSK Poliovirus Vaccine Product Portfolio Table 80. GSK Recent Development Table 81. Tiantan Biological Company Information Table 82. Tiantan Biological Business Overview Table 83. Tiantan Biological Poliovirus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Tiantan Biological Poliovirus Vaccine Product Portfolio Table 85. Tiantan Biological Recent Development Table 86. Serum Institute Company Information Table 87. Serum Institute Business Overview Table 88. Serum Institute Poliovirus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Serum Institute Poliovirus Vaccine Product Portfolio Table 90. Serum Institute Recent Development Table 91. Panacea Biotec Ltd Company Information Table 92. Panacea Biotec Ltd Business Overview Table 93. Panacea Biotec Ltd Poliovirus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Panacea Biotec Ltd Poliovirus Vaccine Product Portfolio Table 95. Panacea Biotec Ltd Recent Development Table 96. IMBCA Company Information Table 97. IMBCA Business Overview Table 98. IMBCA Poliovirus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. IMBCA Poliovirus Vaccine Product Portfolio Table 100. IMBCA Recent Development Table 101. Halfkin Bio-Pharmaceuticals Company Information Table 102. Halfkin Bio-Pharmaceuticals Business Overview Table 103. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolio Table 105. Halfkin Bio-Pharmaceuticals Recent Development Table 106. Bio-Med Company Information Table 107. Bio-Med Business Overview Table 108. Bio-Med Poliovirus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Bio-Med Poliovirus Vaccine Product Portfolio Table 110. Bio-Med Recent Development Table 111. Bibcol Company Information Table 112. Bibcol Business Overview Table 113. Bibcol Poliovirus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Bibcol Poliovirus Vaccine Product Portfolio Table 115. Bibcol Recent Development Table 116. North America Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. North America Poliovirus Vaccine Sales by Country (2021-2026) & (k units) Table 118. North America Poliovirus Vaccine Sales Market Share by Country (2021-2026) Table 119. North America Poliovirus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 120. North America Poliovirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. North America Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Poliovirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Poliovirus Vaccine Market Share by Country (2021-2026) Table 124. North America Poliovirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Poliovirus Vaccine Market Share Forecast by Country (2027-2032) Table 126. Europe Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Europe Poliovirus Vaccine Sales by Country (2021-2026) & (k units) Table 128. Europe Poliovirus Vaccine Sales Market Share by Country (2021-2026) Table 129. Europe Poliovirus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 130. Europe Poliovirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Poliovirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Poliovirus Vaccine Market Share by Country (2021-2026) Table 134. Europe Poliovirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Poliovirus Vaccine Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Poliovirus Vaccine Sales by Country (2021-2026) & (k units) Table 138. Asia-Pacific Poliovirus Vaccine Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Poliovirus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 140. Asia-Pacific Poliovirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Poliovirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Poliovirus Vaccine Market Share by Country (2021-2026) Table 144. Asia-Pacific Poliovirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Poliovirus Vaccine Market Share Forecast by Country (2027-2032) Table 146. Latin America Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Latin America Poliovirus Vaccine Sales by Country (2021-2026) & (k units) Table 148. Latin America Poliovirus Vaccine Sales Market Share by Country (2021-2026) Table 149. Latin America Poliovirus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 150. Latin America Poliovirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Poliovirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Poliovirus Vaccine Market Share by Country (2021-2026) Table 154. Latin America Poliovirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Poliovirus Vaccine Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Poliovirus Vaccine Sales by Country (2021-2026) & (k units) Table 158. Middle East and Africa Poliovirus Vaccine Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Poliovirus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 160. Middle East and Africa Poliovirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Poliovirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Poliovirus Vaccine Market Share by Country (2021-2026) Table 164. Middle East and Africa Poliovirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Poliovirus Vaccine Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Poliovirus Vaccine Distributors List Table 169. Poliovirus Vaccine Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Poliovirus Vaccine Image Figure 2. Global Poliovirus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poliovirus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Poliovirus Vaccine Sales (2021-2032) & (k units) Figure 5. Inactivated Polio Vaccine (IPV) Image Figure 6. Global Inactivated Polio Vaccine (IPV) Sales YoY Growth (2021-2032) & (k units) Figure 7. Oral Polio Vaccine (OPV) Image Figure 8. Global Oral Polio Vaccine (OPV) Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Poliovirus Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Poliovirus Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Poliovirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Poliovirus Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Poliovirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Poliovirus Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Poliovirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Poliovirus Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Poliovirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Poliovirus Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Poliovirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Poliovirus Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Poliovirus Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Public Image Figure 24. Global Public Sales YoY Growth (2021-2032) & (k units) Figure 25. Private Image Figure 26. Global Private Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Poliovirus Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Poliovirus Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Poliovirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Poliovirus Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Poliovirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Poliovirus Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Poliovirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Poliovirus Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Poliovirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Poliovirus Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Poliovirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Poliovirus Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Poliovirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Poliovirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Poliovirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Poliovirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Poliovirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Poliovirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Poliovirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Poliovirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Poliovirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Poliovirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Poliovirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Poliovirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Poliovirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Poliovirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Poliovirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Poliovirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Poliovirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Poliovirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Poliovirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Poliovirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Poliovirus Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Poliovirus Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Polio Vaccine (IPV)
  • Oral Polio Vaccine (OPV)
Applications
  • Public
  • Private
Companies covered
  • Sanofi
  • GSK
  • Tiantan Biological
  • Serum Institute
  • Panacea Biotec Ltd
  • IMBCA
  • Halfkin Bio-Pharmaceuticals
  • Bio-Med
  • Bibcol

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Poliovirus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Poliovirus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Poliovirus Vaccine Market by Type
  6. 1.3.1 Inactivated Polio Vaccine (IPV)
  7. 1.3.2 Oral Polio Vaccine (OPV)
  8. 1.4 Global Poliovirus Vaccine Market Size by Type
  9. 1.4.1 Global Poliovirus Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Poliovirus Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Poliovirus Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Poliovirus Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Poliovirus Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Poliovirus Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Poliovirus Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Poliovirus Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Poliovirus Vaccine Industry Trends
  2. 2.2 Poliovirus Vaccine Industry Drivers
  3. 2.3 Poliovirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Poliovirus Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Poliovirus Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Poliovirus Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Poliovirus Vaccine Price (2021-2026)
  4. 3.4 Global Poliovirus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Poliovirus Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Poliovirus Vaccine Company, Product Type & Application
  7. 3.7 Global Poliovirus Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Poliovirus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Poliovirus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Poliovirus Vaccine Tier 1, Tier 2, and Tier 3
4 Poliovirus Vaccine Regional Status and Outlook
  1. 4.1 Global Poliovirus Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Poliovirus Vaccine Historic Market Size by Region
  3. 4.2.1 Global Poliovirus Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Poliovirus Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Poliovirus Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Poliovirus Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Poliovirus Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Poliovirus Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Poliovirus Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Poliovirus Vaccine by Application
  1. 5.1 Poliovirus Vaccine Market by Application
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Poliovirus Vaccine Market Size by Application
  5. 5.2.1 Global Poliovirus Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Poliovirus Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Poliovirus Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Poliovirus Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Poliovirus Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Poliovirus Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Poliovirus Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Poliovirus Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Poliovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Poliovirus Vaccine Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Poliovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Poliovirus Vaccine Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Tiantan Biological
  14. 6.3.1 Tiantan Biological Company Information
  15. 6.3.2 Tiantan Biological Business Overview
  16. 6.3.3 Tiantan Biological Poliovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tiantan Biological Poliovirus Vaccine Product Portfolio
  18. 6.3.5 Tiantan Biological Recent Developments
  19. 6.4 Serum Institute
  20. 6.4.1 Serum Institute Company Information
  21. 6.4.2 Serum Institute Business Overview
  22. 6.4.3 Serum Institute Poliovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Serum Institute Poliovirus Vaccine Product Portfolio
  24. 6.4.5 Serum Institute Recent Developments
  25. 6.5 Panacea Biotec Ltd
  26. 6.5.1 Panacea Biotec Ltd Company Information
  27. 6.5.2 Panacea Biotec Ltd Business Overview
  28. 6.5.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Panacea Biotec Ltd Poliovirus Vaccine Product Portfolio
  30. 6.5.5 Panacea Biotec Ltd Recent Developments
  31. 6.6 IMBCA
  32. 6.6.1 IMBCA Company Information
  33. 6.6.2 IMBCA Business Overview
  34. 6.6.3 IMBCA Poliovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 IMBCA Poliovirus Vaccine Product Portfolio
  36. 6.6.5 IMBCA Recent Developments
  37. 6.7 Halfkin Bio-Pharmaceuticals
  38. 6.7.1 Halfkin Bio-Pharmaceuticals Company Information
  39. 6.7.2 Halfkin Bio-Pharmaceuticals Business Overview
  40. 6.7.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolio
  42. 6.7.5 Halfkin Bio-Pharmaceuticals Recent Developments
  43. 6.8 Bio-Med
  44. 6.8.1 Bio-Med Company Information
  45. 6.8.2 Bio-Med Business Overview
  46. 6.8.3 Bio-Med Poliovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bio-Med Poliovirus Vaccine Product Portfolio
  48. 6.8.5 Bio-Med Recent Developments
  49. 6.9 Bibcol
  50. 6.9.1 Bibcol Company Information
  51. 6.9.2 Bibcol Business Overview
  52. 6.9.3 Bibcol Poliovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bibcol Poliovirus Vaccine Product Portfolio
  54. 6.9.5 Bibcol Recent Developments
7 North America by Country
  1. 7.1 North America Poliovirus Vaccine Sales by Country
  2. 7.1.1 North America Poliovirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Poliovirus Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Poliovirus Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Poliovirus Vaccine Market Size by Country
  6. 7.2.1 North America Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Poliovirus Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Poliovirus Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Poliovirus Vaccine Sales by Country
  2. 8.1.1 Europe Poliovirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Poliovirus Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Poliovirus Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Poliovirus Vaccine Market Size by Country
  6. 8.2.1 Europe Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Poliovirus Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Poliovirus Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Poliovirus Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Poliovirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Poliovirus Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Poliovirus Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Poliovirus Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Poliovirus Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Poliovirus Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Poliovirus Vaccine Sales by Country
  2. 10.1.1 South America Poliovirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Poliovirus Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Poliovirus Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Poliovirus Vaccine Market Size by Country
  6. 10.2.1 South America Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Poliovirus Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Poliovirus Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Poliovirus Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Poliovirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Poliovirus Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Poliovirus Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Poliovirus Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Poliovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Poliovirus Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Poliovirus Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Poliovirus Vaccine Value Chain Analysis
  2. 12.1.1 Poliovirus Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Poliovirus Vaccine Production Mode & Process
  7. 12.2 Poliovirus Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Poliovirus Vaccine Distributors
  10. 12.2.3 Poliovirus Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst